Loading...
GNS logo

Genus plcLSE:GNS Stock Report

Market Cap UK£1.7b
Share Price
UK£24.75
My Fair Value
UK£28.41
12.9% undervalued intrinsic discount
1Y29.7%
7D-8.7%
Portfolio Value
​
View

Genus plc

LSE:GNS Stock Report

Market Cap: UK£1.7b

Genus (GNS) Stock Overview

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. More details

GNS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth4/6
Past Performance3/6
Financial Health4/6
Dividends3/6

Rewards

Trading at 8.6% below our estimate of its fair value

Earnings are forecast to grow 24.78% per year

Earnings grew by 144.3% over the past year

Risk Analysis

Large one-off items impacting financial results


GNS Community Fair Values

Create Narrative

See what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.

GNS logo
Genus

Regulatory Pressures And Plant-Based Trends Will Erode Future Profitability

Key Takeaways Structural shifts towards alternative proteins and increased scrutiny on animal genetics threaten Genus's market relevance, revenue growth, and long-term earnings stability. Heavy R&D dependence and complex regulation expose Genus to margin compression, strained cash flows, and volatile profitability amid rising global compliance costs.
View narrative
UK£18.79
FV
31.7% overvalued intrinsic discount
4.02%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
15 days ago author updated this narrative
GNS logo
Genus

Growing Global Protein Demand Will Accelerate Livestock Genetics

Key Takeaways Faster-than-expected regulatory progress and strategic partnerships position Genus for significant revenue and margin expansion, especially in the Chinese market. Leadership in advanced genetics and deepening presence in emerging markets strengthen Genus' premium pricing and future growth opportunities.
View narrative
UK£35
FV
29.3% undervalued intrinsic discount
6.16%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
8 days ago author updated this narrative
GNS logo
Genus

FDA Approval Of PRP Program In 2025 Will Open Significant Revenue Stream

Key Takeaways Growth in the porcine division and strategic partnerships in China are expected to enhance Genus's revenue and earnings. Expansion in the bovine segment through acquisitions and programs like VAP is projected to improve profit margins and financial stability.
View narrative
UK£27.97
FV
11.5% undervalued intrinsic discount
4.92%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
8 days ago author updated this narrative
View Stock Community

Genus plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Genus
Historical stock prices
Current Share PriceUK£24.75
52 Week HighUK£32.29
52 Week LowUK£14.24
Beta0.58
1 Month Change-6.78%
3 Month Change26.28%
1 Year Change29.72%
3 Year Change-12.11%
5 Year Change-35.61%
Change since IPO1,733.33%

Recent News & Updates

Genus (LON:GNS) Is Due To Pay A Dividend Of £0.217

Sep 07
Genus (LON:GNS) Is Due To Pay A Dividend Of £0.217

Recent updates

Genus (LON:GNS) Is Due To Pay A Dividend Of £0.217

Sep 07
Genus (LON:GNS) Is Due To Pay A Dividend Of £0.217

There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Jul 25
There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Estimating The Fair Value Of Genus plc (LON:GNS)

Jul 22
Estimating The Fair Value Of Genus plc (LON:GNS)

Genus plc (LON:GNS) Stock Catapults 36% Though Its Price And Business Still Lag The Industry

May 10
Genus plc (LON:GNS) Stock Catapults 36% Though Its Price And Business Still Lag The Industry

An Intrinsic Calculation For Genus plc (LON:GNS) Suggests It's 21% Undervalued

Apr 18
An Intrinsic Calculation For Genus plc (LON:GNS) Suggests It's 21% Undervalued
User avatar

Regulatory Approvals And Sustainability Initiatives Will Strengthen Future Market Position

Expansion in the porcine business and PRRS resistant pig commercialization boosts revenue stability and growth through innovation and market penetration.

There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Feb 01
There's No Escaping Genus plc's (LON:GNS) Muted Revenues Despite A 25% Share Price Rise

Lacklustre Performance Is Driving Genus plc's (LON:GNS) Low P/S

Nov 20
Lacklustre Performance Is Driving Genus plc's (LON:GNS) Low P/S

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Oct 23
Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

There May Be Some Bright Spots In Genus' (LON:GNS) Earnings

Oct 22
There May Be Some Bright Spots In Genus' (LON:GNS) Earnings

Genus plc Just Missed EPS By 72%: Here's What Analysts Think Will Happen Next

Sep 08
Genus plc Just Missed EPS By 72%: Here's What Analysts Think Will Happen Next

The Price Is Right For Genus plc (LON:GNS)

Jun 16
The Price Is Right For Genus plc (LON:GNS)

Estimating The Fair Value Of Genus plc (LON:GNS)

Apr 20
Estimating The Fair Value Of Genus plc (LON:GNS)

Is Genus (LON:GNS) Using Too Much Debt?

Mar 25
Is Genus (LON:GNS) Using Too Much Debt?

With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For

Mar 05
With A 26% Price Drop For Genus plc (LON:GNS) You'll Still Get What You Pay For

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103

Feb 25
Genus (LON:GNS) Has Affirmed Its Dividend Of £0.103

Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult

Jan 17
Getting In Cheap On Genus plc (LON:GNS) Might Be Difficult

Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?

Dec 10
Does This Valuation Of Genus plc (LON:GNS) Imply Investors Are Overpaying?

We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt

Nov 03
We Think Genus (LON:GNS) Is Taking Some Risk With Its Debt

Calculating The Intrinsic Value Of Genus plc (LON:GNS)

Sep 09
Calculating The Intrinsic Value Of Genus plc (LON:GNS)

Is Genus (LON:GNS) A Risky Investment?

Mar 29
Is Genus (LON:GNS) A Risky Investment?

Is Genus (LON:GNS) Using Too Much Debt?

Dec 21
Is Genus (LON:GNS) Using Too Much Debt?

It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year

Nov 17
It's Unlikely That Shareholders Will Increase Genus plc's (LON:GNS) Compensation By Much This Year

Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Oct 25
Genus (LON:GNS) Has Affirmed Its Dividend Of £0.217

Genus (LON:GNS) Is Paying Out A Dividend Of £0.217

Oct 11
Genus (LON:GNS) Is Paying Out A Dividend Of £0.217

Genus' (LON:GNS) Dividend Will Be £0.217

Sep 11
Genus' (LON:GNS) Dividend Will Be £0.217

A Look At The Fair Value Of Genus plc (LON:GNS)

Sep 09
A Look At The Fair Value Of Genus plc (LON:GNS)

A Look At The Intrinsic Value Of Genus plc (LON:GNS)

May 31
A Look At The Intrinsic Value Of Genus plc (LON:GNS)

Is Genus (LON:GNS) A Risky Investment?

Mar 29
Is Genus (LON:GNS) A Risky Investment?

Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10

Feb 27
Genus (LON:GNS) Has Re-Affirmed Its Dividend Of UK£0.10

Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 22
Is Genus plc (LON:GNS) Expensive For A Reason? A Look At Its Intrinsic Value

Shareholder Returns

GNSGB BiotechsGB Market
7D-8.7%-3.4%-0.08%
1Y29.7%11.7%10.4%

Return vs Industry: GNS exceeded the UK Biotechs industry which returned 11.7% over the past year.

Return vs Market: GNS exceeded the UK Market which returned 10.4% over the past year.

Price Volatility

Is GNS's price volatile compared to industry and market?
GNS volatility
GNS Average Weekly Movement5.3%
Biotechs Industry Average Movement8.3%
Market Average Movement4.7%
10% most volatile stocks in GB Market10.6%
10% least volatile stocks in GB Market2.5%

Stable Share Price: GNS has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: GNS's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19943,500JK Kokkewww.genusplc.com

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Genus plc Fundamentals Summary

How do Genus's earnings and revenue compare to its market cap?
GNS fundamental statistics
Market capUK£1.66b
Earnings (TTM)UK£19.30m
Revenue (TTM)UK£672.80m
84.2x
P/E Ratio
2.4x
P/S Ratio

Is GNS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GNS income statement (TTM)
RevenueUK£672.80m
Cost of RevenueUK£0
Gross ProfitUK£672.80m
Other ExpensesUK£653.50m
EarningsUK£19.30m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.29
Gross Margin100.00%
Net Profit Margin2.87%
Debt/Equity Ratio46.0%

How did GNS perform over the long term?

See historical performance and comparison

Dividends

1.3%
Current Dividend Yield
109%
Payout Ratio

Does GNS pay a reliable dividends?

See GNS dividend history and benchmarks
When do you need to buy GNS by to receive an upcoming dividend?
Genus dividend dates
Ex Dividend DateNov 06 2025
Dividend Pay DateDec 05 2025
Days until Ex dividend48 days
Days until Dividend pay date77 days

Does GNS pay a reliable dividends?

See GNS dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/18 17:27
End of Day Share Price 2025/09/18 00:00
Earnings2025/06/30
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genus plc is covered by 20 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert ChantryBerenberg
Alexander JonesBofA Global Research
Matthew John YatesBofA Global Research